Mechanisms of Altered Ca2+ Handling in Heart Failure

M Luo, ME Anderson - Circulation research, 2013 - Am Heart Assoc
Ca2+ plays a crucial role in connecting membrane excitability with contraction in
myocardium. The hallmark features of heart failure are mechanical dysfunction and …

Animal models to study cardiac arrhythmias

DJ Blackwell, J Schmeckpeper… - Circulation research, 2022 - Am Heart Assoc
Cardiac arrhythmias are a significant cause of morbidity and mortality worldwide, accounting
for 10% to 15% of all deaths. Although most arrhythmias are due to acquired heart disease …

Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality

K Zsebo, A Yaroshinsky, JJ Rudy, K Wagner… - Circulation …, 2014 - Am Heart Assoc
Rationale: The Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In
Cardiac Disease (CUPID 1) study was a phase 1/phase 2 first-in-human clinical gene …

Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by …

B Greenberg, A Yaroshinsky, KM Zsebo, J Butler… - JACC: Heart Failure, 2014 - jacc.org
Objectives: Impaired cardiac isoform of sarco (endo) plasmic reticulum Ca2+ ATPase
(SERCA2a) activity is a key abnormality in heart failure patients with reduced ejection …

[HTML][HTML] The role of CaMKII regulation of phospholamban activity in heart disease

A Mattiazzi, EG Kranias - Frontiers in pharmacology, 2014 - frontiersin.org
Phospholamban (PLN) is a phosphoprotein in cardiac sarcoplasmic reticulum (SR) that is a
reversible regulator of the Ca2+-ATPase (SERCA2a) activity and cardiac contractility …

[PDF][PDF] Microproteins: Overlooked regulators of physiology and disease

KR Hassel, O Brito-Estrada, CA Makarewich - Iscience, 2023 - cell.com
Ongoing efforts to generate a complete and accurate annotation of the genome have
revealed a significant blind spot for small proteins (< 100 amino acids) originating from short …

[HTML][HTML] Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device …

AR Lyon, D Babalis, AC Morley-Smith, M Hedger… - Gene therapy, 2020 - nature.com
The SERCA-LVAD trial was a phase 2a trial assessing the safety and feasibility of delivering
an adeno-associated vector 1 carrying the cardiac isoform of the sarcoplasmic reticulum …

[HTML][HTML] Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy

SK Das, W Wang, P Zhabyeyev, R Basu, B McLean… - Scientific reports, 2015 - nature.com
Iron-overload cardiomyopathy is a prevalent cause of heart failure on a world-wide basis
and is a major cause of mortality and morbidity in patients with secondary iron-overload and …

Biosynthetic nanobubbles for targeted gene delivery by focused ultrasound

B Tayier, Z Deng, Y Wang, W Wang, Y Mu, F Yan - Nanoscale, 2019 - pubs.rsc.org
Ultrasound-targeted microbubble destruction (UTMD) has recently drawn considerable
attention in biomedicine applications due to its great potential to locally enhance gene …

Extracellular Vesicle–Encapsulated Adeno-Associated Viruses for Therapeutic Gene Delivery to the Heart

X Li, S La Salvia, Y Liang, M Adamiak, E Kohlbrenner… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Adeno-associated virus (AAV) has emerged as one of the best tools for
cardiac gene delivery due to its cardiotropism, long-term expression, and safety. However, a …